HIA
VRTX icon

Harbor Investment Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History

Harbor Investment Advisory’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$695K Hold
1,399
– – 0.05% 253
2026
Q1 		$625K Buy
1,399
+305
+28% +$142K 0.05% 253
2025
Q4 		$496K Sell
1,094
-59
-5% -$25.4K 0.04% 286
2025
Q3 		$452K Sell
1,153
-321
-22% -$134K 0.04% 290
2025
Q2 		$656K Hold
1,474
– – 0.06% 228
2025
Q1 		$715K Sell
1,474
-419
-22% -$195K 0.07% 198
2024
Q4 		$762K Sell
1,893
-315
-14% -$146K 0.07% 183
2024
Q3 		$1.03M Sell
2,208
-11
-0.5% -$5.28K 0.1% 158
2024
Q2 		$1.04M Buy
2,219
+1
+0% +$434 0.11% 139
2024
Q1 		$927K Hold
2,218
– – 0.1% 161
2023
Q4 		$902K Buy
2,218
+1,314
+145% +$485K 0.1% 151
2023
Q3 		$314K Buy
904
+50
+6% +$17.5K 0.04% 255
2023
Q2 		$301K Hold
854
– – 0.04% 285
2023
Q1 		$269K Sell
854
-200
-19% -$60K 0.04% 298
2022
Q4 		$304K Sell
1,054
-110
-9% -$33.5K 0.05% 275
2022
Q3 		$337K Hold
1,164
– – 0.06% 248
2022
Q2 		$328K Hold
1,164
– – 0.05% 251
2022
Q1 		$304K Buy
1,164
+150
+15% +$35.6K 0.04% 286
2021
Q4 		$223K Buy
1,014
+796
+365% +$155K 0.03% 357
2021
Q3 		$40K Sell
218
-437
-67% -$85.3K 0.01% 801
2021
Q2 		$132K Buy
655
+218
+50% +$45.6K 0.02% 447
2021
Q1 		$94K Buy
437
+55
+14% +$12.1K 0.01% 500
2020
Q4 		$90K Sell
382
-73
-16% -$16.7K 0.01% 481
2020
Q3 		$124K Sell
455
-671
-60% -$185K 0.02% 345
2020
Q2 		$327K Buy
1,126
+762
+209% +$207K 0.07% 191
2020
Q1 		$87K Buy
364
+108
+42% +$24.8K 0.02% 334
2019
Q4 		$56K Buy
+256
New +$51.8K 0.01% 398

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Harbor Investment Advisory's VRTX Position: Q2 2026 in Review

Harbor Investment Advisory held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 1,399 shares worth $695K. The position accounts for 0.05% of the portfolio, ranked #253.

Harbor Investment Advisory first reported a position in VRTX in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.04M in Q2 2024. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Harbor Investment Advisory held 1,399 shares of Vertex Pharmaceuticals worth $695K as of Q2 2026.
  • Harbor Investment Advisory left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.05% of Harbor Investment Advisory's portfolio in Q2 2026, its #253 holding.
  • Harbor Investment Advisory first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • Harbor Investment Advisory's Vertex Pharmaceuticals position peaked at $1.04M in Q2 2024.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.